Pacer Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.06M | Sell |
43,794
-12,417
| -22% | -$868K | 0.01% | 849 |
|
2025
Q1 | $4.13M | Buy |
56,211
+769
| +1% | +$56.5K | 0.01% | 711 |
|
2024
Q4 | $3.63M | Buy |
55,442
+498
| +0.9% | +$32.6K | 0.01% | 737 |
|
2024
Q3 | $4.28M | Sell |
54,944
-106
| -0.2% | -$8.26K | 0.01% | 666 |
|
2024
Q2 | $4.29M | Sell |
55,050
-216
| -0.4% | -$16.8K | 0.01% | 617 |
|
2024
Q1 | $3.74M | Sell |
55,266
-508
| -0.9% | -$34.4K | 0.01% | 662 |
|
2023
Q4 | $3.76M | Buy |
55,774
+3,246
| +6% | +$219K | 0.01% | 627 |
|
2023
Q3 | $3.56M | Buy |
52,528
+8,215
| +19% | +$556K | 0.01% | 515 |
|
2023
Q2 | $3.17M | Sell |
44,313
-13,997
| -24% | -$1M | 0.01% | 614 |
|
2023
Q1 | $4.05M | Buy |
58,310
+17,753
| +44% | +$1.23M | 0.02% | 588 |
|
2022
Q4 | $2.75M | Buy |
40,557
+23,405
| +136% | +$1.59M | 0.01% | 518 |
|
2022
Q3 | $941K | Buy |
17,152
+448
| +3% | +$24.6K | 0.01% | 554 |
|
2022
Q2 | $1.1M | Buy |
+16,704
| New | +$1.1M | 0.01% | 526 |
|
2022
Q1 | – | Sell |
-23,498
| Closed | -$1.37M | – | 2286 |
|
2021
Q4 | $1.37M | Sell |
23,498
-291
| -1% | -$17K | 0.01% | 1019 |
|
2021
Q3 | $1.43M | Buy |
23,789
+3,250
| +16% | +$195K | 0.02% | 747 |
|
2021
Q2 | $1.23M | Buy |
20,539
+600
| +3% | +$35.9K | 0.02% | 773 |
|
2021
Q1 | $991K | Sell |
19,939
-1,733
| -8% | -$86.1K | 0.02% | 776 |
|
2020
Q4 | $1.08M | Sell |
21,672
-4,840
| -18% | -$242K | 0.02% | 663 |
|
2020
Q3 | $1.45M | Buy |
+26,512
| New | +$1.45M | 0.03% | 543 |
|
2020
Q1 | – | Sell |
-19,950
| Closed | -$995K | – | 699 |
|
2019
Q4 | $995K | Buy |
19,950
+5,902
| +42% | +$294K | 0.04% | 547 |
|
2019
Q3 | $626K | Buy |
14,048
+5,188
| +59% | +$231K | 0.01% | 950 |
|
2019
Q2 | $366K | Buy |
+8,860
| New | +$366K | 0.01% | 1013 |
|
2013
Q4 | $605K | Buy |
+17,188
| New | +$605K | 0.15% | 191 |
|